Figure 1. Teneligliptin improved the dyslipidemia in db/db mice. (A) Total cholesterol (TC) level; (B) Triglyceride (TG) in level; (C) Low-density lipoprotein cholesterol (LDL-C) level (*, **P < 0.05, 0.01 vs. db/db mice group; †, ††P < 0.05, 0.01 vs. Teneligliptin group).